These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32000446)
1. Prognostic value of 18F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma. Dissaux G; Basse V; Schick U; El Kabbaj O; Auberger B; Magro E; Kassoul A; Abgral R; Salaun PY; Bourhis D; Querellou S Medicine (Baltimore); 2020 Jan; 99(5):e19017. PubMed ID: 32000446 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of O-(2-[ Kertels O; Kessler AF; Mihovilovic MI; Stolzenburg A; Linsenmann T; Samnick S; Brändlein S; Monoranu CM; Ernestus RI; Buck AK; Löhr M; Lapa C Mol Imaging Biol; 2019 Dec; 21(6):1174-1181. PubMed ID: 30977078 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study. Bashir A; Brennum J; Broholm H; Law I J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154 [TBL] [Abstract][Full Text] [Related]
4. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. Albert NL; Winkelmann I; Suchorska B; Wenter V; Schmid-Tannwald C; Mille E; Todica A; Brendel M; Tonn JC; Bartenstein P; la Fougère C Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1105-14. PubMed ID: 26666239 [TBL] [Abstract][Full Text] [Related]
5. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma. Galldiks N; Stoffels G; Ruge MI; Rapp M; Sabel M; Reifenberger G; Erdem Z; Shah NJ; Fink GR; Coenen HH; Langen KJ J Nucl Med; 2013 Dec; 54(12):2046-54. PubMed ID: 24159047 [TBL] [Abstract][Full Text] [Related]
6. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy. Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
8. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ Bauer EK; Stoffels G; Blau T; Reifenberger G; Felsberg J; Werner JM; Lohmann P; Rosen J; Ceccon G; Tscherpel C; Rapp M; Sabel M; Filss CP; Shah NJ; Neumaier B; Fink GR; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446 [TBL] [Abstract][Full Text] [Related]
9. Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485 [TBL] [Abstract][Full Text] [Related]
10. Static Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141 [TBL] [Abstract][Full Text] [Related]
11. Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas. Pyka T; Gempt J; Hiob D; Ringel F; Schlegel J; Bette S; Wester HJ; Meyer B; Förster S Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):133-141. PubMed ID: 26219871 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. Jansen NL; Suchorska B; Wenter V; Schmid-Tannwald C; Todica A; Eigenbrod S; Niyazi M; Tonn JC; Bartenstein P; Kreth FW; la Fougère C J Nucl Med; 2015 Jan; 56(1):9-15. PubMed ID: 25537990 [TBL] [Abstract][Full Text] [Related]
14. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas. Blanc-Durand P; Van Der Gucht A; Verger A; Langen KJ; Dunet V; Bloch J; Brouland JP; Nicod-Lalonde M; Schaefer N; Prior JO PLoS One; 2018; 13(6):e0199379. PubMed ID: 29953478 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386 [TBL] [Abstract][Full Text] [Related]
16. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense? Unterrainer M; Schweisthal F; Suchorska B; Wenter V; Schmid-Tannwald C; Fendler WP; Schüller U; Bartenstein P; Tonn JC; Albert NL J Nucl Med; 2016 Aug; 57(8):1177-82. PubMed ID: 27033893 [TBL] [Abstract][Full Text] [Related]
17. Static and dynamic Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400 [TBL] [Abstract][Full Text] [Related]
18. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540 [TBL] [Abstract][Full Text] [Related]